Showing 1 - 11 results of 11 for search 'Van Oosterhout, J', query time: 0.03s
Refine Results
-
1
Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analys... by Thompson, J, Kityo, C, Dunn, D, Hoppe, A, Ndashimye, E, Hakim, J, Kambugu, A, van Oosterhout, J, Arribas, J, Mugyenyi, P, Walker, A, Paton, N
Published 2018Journal article -
2
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the... by Paton, N, Kityo, C, Thompson, J, Nankya, I, Bagenda, L, Hoppe, A, Hakim, J, Kambugu, A, van Oosterhout, J, Kinconco, M, Bertagnolio, S, Easterbrook, P, Mugyenyi, P, Walker, A
Published 2017Journal article -
3
Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia. by Ellis, J, L'homme, R, Ewings, F, Mulenga, V, Bell, F, Chileshe, R, Molyneux, E, Abernethy, J, van Oosterhout, J, Chintu, C, Walker, A, Gibb, D, Burger, D
Published 2007Journal article -
4
Evaluating the reactivation of herpesviruses and inflammation as cardiovascular and cerebrovascular risk factors in antiretroviral therapy initiators in an African HIV-infected pop... by Peterson, I, Ntsui, N, Jambo, K, Kelly, C, Huwa, J, Afran, L, Tatuene, JK, Pett, S, Henrion, MYR, Van Oosterhout, J, Heyderman, RS, Mwandumba, H, Benjamin, LA, Investigators of the RHICCA study
Published 2019Journal article -
5
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up resu... by Hakim, J, Thompson, J, Kityo, C, Hoppe, A, Kambugu, A, van Oosterhout, J, Lugemwa, A, Siika, A, Mwebaze, R, Mweemba, A, Abongomera, G, Thomason, M, Easterbrook, P, Mugyenyi, P, Walker, A, Paton, N
Published 2017Journal article -
6
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up resu... by Hakim, J, Thompson, J, Kityo, C, Hoppe, A, Kambugu, A, van Oosterhout, J, Lugemwa, A, Siika, A, Mwebaze, R, Mweemba, A, Abongomera, G, Thomason, M, Easterbrook, P, Mugyenyi, P, Walker, A, Paton, N
Published 2017Journal article -
7
HIV drug resistance mutations in non-B subtypes after prolonged virological failure on NNRTI-based first-line regimens in sub-Saharan Africa by Kityo, C, Thompson, J, Nankya, I, Hoppe, A, Ndashimye, E, Warambwa, C, Mambule, I, van Oosterhout, J, Wools-Kaloustian, K, Bertagnolio, S, Easterbrook, P, Mugyenyi, P, Walker, A, Paton, N, For the Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST)Trial Team
Published 2017Journal article -
8
Assessment of second-line antiretroviral regimens for HIV therapy in Africa. by Paton, N, Kityo, C, Hoppe, A, Reid, A, Kambugu, A, Lugemwa, A, van Oosterhout, J, Kiconco, M, Siika, A, Mwebaze, R, Abwola, M, Abongomera, G, Mweemba, A, Alima, H, Atwongyeire, D, Nyirenda, R, Boles, J, Thompson, J, Tumukunde, D, Chidziva, E, Mambule, I, Arribas, JR, Easterbrook, P, Hakim, J, Walker, A, Mugyenyi, P
Published 2014Journal article -
9
Adjunctive dexamethasone in HIV-associated cryptococcal meningitis by Beardsley, J, Wolbers, M, Kibengo, F, Ggayi, A, Kamali, A, Cuc, N, Binh, T, Chau, N, Farrar, J, Merson, L, Phuong, L, Thwaites, G, Van Kinh, N, Thuy, P, Chierakul, W, Siriboon, S, Thiansukhon, E, Onsanit, S, Supphamongkholchaikul, W, Chan, A, Heyderman, R, Mwinjiwa, E, van Oosterhout, J, Imran, D, Basri, H, Mayxay, M, Dance, D, Phimmasone, P, Rattanavong, S, Lalloo, D, Day, J
Published 2016Journal article -
10
CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a rand... by Day, N, Imran, D, Ganiem, A, Tjahjani, N, Wahyuningsih, R, Adawiyah, R, Dance, D, Mayxay, M, Newton, P, Phetsouvanh, R, Rattanavong, S, Chan, A, Heyderman, R, van Oosterhout, J, Chierakul, W, Day, J, Kamali, A, Kibengo, F, Ruzagira, E, Gray, A, Lalloo, D, Beardsley, J, Binh, T, Chau, T, Chau, N, Cuc, N, Farrar, J, Hien, T, Van Kinh, N, Merson, L, Phuong, L, Tho, L, Thuy, P, Thwaites, G, Wertheim, H, Wolbers, M
Published 2014Journal article -
11
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries by Loyse, A, Burry, J, Cohn, J, Ford, N, Chiller, T, Ribeiro, I, Koulla-Shiro, S, Mghamba, J, Ramadhani, A, Nyirenda, R, Aliyu, SH, Wilson, D, Le, T, Oladele, R, Lesikari, S, Muzoora, C, Kalata, N, Temfack, E, Mapoure, Y, Sini, V, Chanda, D, Shimwela, M, Lakhi, S, Ngoma, J, Gondwe-Chunda, L, Perfect, C, Shroufi, A, Andrieux-Meyer, I, Chan, A, Schutz, C, Hosseinipour, M, Van Der Horst, C, Klausner, JD, Boulware, DR, Heyderman, R, Lalloo, D, Day, J, Jarvis, JN, Rodrigues, M, Jaffar, S, Denning, D, Migone, C, Doherty, M, Lortholary, O, Dromer, F, Stack, M, Molloy, SF, Bicanic, T, Van Oosterhout, J, Mwaba, P, Kanyama, C, Kouanfack, C, Mfinanga, S, Govender, N, Harrison, TS
Published 2018Journal article